Vered Bisker-Leib
CHIEF EXECUTIVE OFFICER at Compass Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Compass Therapeutics Inc., 2 years.
Compass Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Compass Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 8, 2024 | Compass Therapeutics Inc. | Shares withheld for tax | −49,198 | $1.45 | $71,337 |
| Jan 9, 2024 | Compass Therapeutics Inc. | Grant or award | +1,753,125 | $1.93 | $3,383,531 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.